6Choi YM,Shim KS,Yoon KL,et al.Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease[J].Korean J Pediatr,2012,55(1):18-23.
7Takeuchi D,Saji T,Takatsuki S,et al.Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease[J].Circ J,2007,71(3):357-362.
8Noor R,Shuaib U,Wang CX,et al.High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing e NOS and preventing apoptosis[J].Atherosclerosis,2007,192(1):92-99.
4Ghelani SJ,Sable C,Wiedermann BL,et al.Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association Guidelines[J].Pediatr Cardiol,2012,33(7):1 097-1 103.
5Japanese Circulation Society Joint Working Group.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease(JSC 2008)-digest version[J].Circ J,2010,74(9):1 989-2 020.
6Brogan PA,Bose A,Burgner D,et al.Kawasiki disease:an evidence based approach to diagnosis,treatment,and proposals for future research[J].Arch Dis Child,2002,86(4):286-290.
8Nakamura Y,Yashiro M,Uehara R,et al.Epidemiologic features of Kawasaki disease in Japan:Results of the 2007-2008 nationwide survey[J].J Epidemiol,2010,20(4):302-307.
9Park YW,Han JW,Hong YM,et al.Epidemiological features of Kawasaki disease in Korea,2006-2008[J].Pediatr Int,2011,53(1):36-39.
10Lin YT,Manlhiot C,Ching JC,et al.Repeated systematic surveillance of Kawasaki disease in Ontario from 1995to 2006[J].Pediatr Int,2010,52:699-706.
